PT-141 (Bremelanotide) · Research brief

Where to Buy PT-141 — Sourcing Research Bremelanotide

Real Peptides Research TeamEditorial

Updated September 16, 20269 min read

54 WORDS

Short answer

Two vials labeled PT-141 10mg can hold measurably different amounts of actual peptide. Residual trifluoroacetic acid salt and bound moisture occupy part of the powder mass, which means the cheaper vial is sometimes the more expensive one per milligram of compound. That single fact explains most of the confusion about where to buy PT-141.

Key takeaways

A batch-specific certificate showing HPLC purity and mass spectrometry identity is the minimum standard, so buy PT-141 only against a certificate whose lot number matches the vial in the box.
Purity and net peptide content are two different figures, because trifluoroacetic acid counterion and residual moisture occupy part of the powder mass, which makes price per milligram non-comparable across suppliers when you buy PT-141.
Bremelanotide is a synthetic alpha-MSH analogue acting as a non-selective melanocortin receptor agonist, with central MC4R signaling as the focus of the published research.
Vyleesi, the subcutaneous bremelanotide autoinjector from Palatin Technologies, received FDA approval in 2019 for hypoactive sexual desire disorder in premenopausal women; research-use-only vials are not that product.
Lyophilized powder tolerates short ambient transit, while the genuine handling sensitivity begins after reconstitution, when solutions are kept refrigerated and shielded from light.
Any seller supplying dosing instructions, human-use claims, or a bundled injection kit is showing you exactly how much regulatory exposure it carries.

We ship research peptides to laboratories and independent researchers every week, and the pre-order questions are almost always the same three: who synthesized it, what does the batch certificate say, and how is it packed for transit. Those three answers separate a usable research vial from an expensive unknown.

Where can you buy PT-141?

Research-grade PT-141 (bremelanotide) is sold by laboratory peptide suppliers that ship lyophilized vials with batch-specific certificates of analysis. The only lawful route to bremelanotide for human use is a prescription for Vyleesi, the approved drug product. Researchers who buy PT-141 for laboratory work should confirm HPLC purity, lot number, and net peptide content before ordering.

The common assumption is that every seller listing the same sequence is selling the same thing. They are not. Synthesis route, purification depth, and post-synthesis handling all change what ends up inside the vial, and none of it is visible on a label. Before you buy PT-141, the practical question is not who posts the lowest price per milligram but who can prove what those milligrams contain. This page covers how to read a batch certificate, how the sourcing channels differ on documentation and recourse, and the red flags that should stop an order before payment clears.

What a batch certificate actually proves

A batch-specific certificate of analysis is the only document that ties the vial in your hand to a real analytical test. Everything else on a product page is copy.

Two tests carry the weight. HPLC (high-performance liquid chromatography) separates the target peptide from truncated sequences and process impurities, and the chromatogram reports purity as an area percentage. Mass spectrometry confirms identity by matching the measured molecular mass against the expected mass for the bremelanotide sequence, which sits just above 1,000 daltons. Purity without identity is meaningless, because a 99% pure something-else is still something else.

Here is the part most sourcing guides skip. Purity and net peptide content are different numbers. Solid-phase peptide synthesis leaves a trifluoroacetic acid counterion bound to the finished peptide, and lyophilized powder also retains residual water. A vial can be 99% pure by HPLC and still sit under its stated mass in actual peptide once salt and moisture are subtracted. Amino acid analysis reports that second number. Anyone about to buy PT-141 should ask for both, because comparing two 10mg listings on price alone compares fill weight, not compound.

Then check that the lot number printed on the vial matches the lot number on the certificate. In our experience reviewing competitor paperwork that researchers send us, that mismatch is the most common documentation failure we see before they buy PT-141 from a new source.

Where to buy PT-141: channels, paperwork, and red flags

Researchers buy PT-141 through three practical channels: dedicated research peptide suppliers, general marketplaces and social sellers, and overseas bulk synthesis houses. They differ less on the molecule and more on what you can verify after the box arrives.

The safest way to buy PT-141 is from a supplier where lot traceability, per-batch analysis, and a stated replacement policy all sit on the same invoice. Real Peptides works in small-batch synthesis with lot-level certificates for exactly this reason: a batch you can trace is a batch you can defend in a write-up.

These are the signals that should end an order:

No lot number on the vial, or a certificate with the lot field blank or cropped out.
The same certificate PDF served for every batch and every product in the catalog.
A seller offering dosing, timing, or administration instructions. Research suppliers cannot do that, and the ones that do are telling you what their compliance looks like.
Language implying the vial is equivalent to a prescription product or suitable for human or veterinary consumption.
Compounds bundled with syringes and bacteriostatic water as a ready-to-use kit.
Pricing far below market for the stated quantity, which usually means shallower purification or a short fill.

Transit matters too. Lyophilized peptide in dry form tolerates several days at ambient temperature, which is why most suppliers ship it dry rather than frozen. The real sensitivity starts after reconstitution, when solutions are held refrigerated and protected from light. Ask about expected transit time before you buy PT-141 in the summer months.

The line between a research vial and a prescription drug

Bremelanotide is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), the signaling molecule that activates the melanocortin receptor family. PT-141 is the research designation. It behaves as a non-selective melanocortin receptor agonist with activity at MC1R, MC3R, and MC4R, and the published sexual-function literature has focused on central MC4R signaling in the hypothalamus. That centrally mediated mechanism is what separates it in the research from PDE5 inhibitors such as sildenafil, which act peripherally on vascular smooth muscle.

The regulatory history is worth knowing. Palatin Technologies developed the compound, discontinued the intranasal formulation after blood pressure increases were observed in clinical work, and brought forward a subcutaneous autoinjector product, Vyleesi, which received FDA approval in 2019 for hypoactive sexual desire disorder in premenopausal women. Nausea, flushing, and headache appear in the reported adverse event profile, and plasma half-life is on the order of a few hours rather than days.

Anyone who chooses to buy PT-141 from a research catalog is not buying Vyleesi. Research-use-only vials are not approved drug products, are not sterile prescription formulations, and are not for human or veterinary consumption. The information here is educational and describes laboratory handling and published research, not dosing or clinical guidance. Anyone weighing a melanocortin compound in an animal-research context should speak with their veterinarian first.

Sourcing channels compared side by side

The table below compares the routes researchers use to buy PT-141 on the three things that actually change outcomes: documentation, traceability, and recourse when a batch is wrong.

Sourcing channel	Documentation typically provided	Traceability and recourse	Bottom line
Dedicated research peptide supplier	Batch-specific COA with HPLC purity and mass spectrometry identity, lot-numbered vials, published certificate archive	Lot traces to a named synthesis batch; replacement and refund terms are written down	Best documentation-to-price balance for most lab work, provided the certificate is lot-matched rather than generic
General marketplace or social seller	Often nothing, or a screenshot certificate with no lot field	No batch traceability, and sellers frequently change accounts between orders	Lowest headline price and the highest unknown; unsuitable wherever analytical certainty matters
Overseas bulk synthesis house	Manufacturer COA, third-party HPLC sometimes available on request, minimum order quantities apply	Traceable at batch level, but customs holds and long transit make returns impractical	Workable for large recurring volumes; poor fit for single-vial or short-timeline research
Prescription pharmacy (Vyleesi)	Full approved product labeling with pharmacy and prescriber oversight	Complete regulatory chain from manufacturer to patient	The only lawful route for human use; not a research supply channel and not sold by peptide catalogs

What If: Sourcing Scenarios Researchers Actually Hit

What if the supplier cannot produce a certificate for my specific lot?

Treat a missing or blank-lot certificate as a failed order and request a refund before the vial is opened. A generic certificate reused across batches proves nothing about the material shipped, because purity shifts batch to batch with synthesis and purification conditions. Suppliers running per-batch analysis send the matching document without friction. If the reply is a cropped screenshot, do not buy PT-141 from that lot.

What if the vial sat in a hot mailbox for two days?

Photograph the package on arrival, record the transit conditions, and contact the supplier before opening it. Lyophilized peptide is comparatively robust in dry form and routinely ships at ambient temperature, but sustained heat can still degrade material, and no bench-level visual check confirms an intact sequence. Analytical confirmation is the only real answer, which is why lot retention samples and a written replacement policy matter more than the ice pack in the box.

What if the powder looks like a thin film instead of a fluffy cake?

Do not assume the vial is defective. Lyophilized peptide presents as a film, a dense puck, or a light cake depending on fill volume, freeze-drying cycle, and mass, and all three are normal at a 10mg fill. What warrants a call is discoloration, visible particulate, or a vial that has lost vacuum. Appearance is a weak signal. The certificate is the strong one.

What if two suppliers list the same 10mg vial at very different prices?

Compare net peptide content and purification depth before concluding one is overpriced. Crude or single-pass material costs far less to produce than twice-purified peptide, and a vial filled to gross mass rather than net peptide mass looks identical on the label. Researchers who buy PT-141 on headline price alone often end up recalculating stock concentrations after the fact, which is the most avoidable source of variance in an otherwise clean experiment.

What if a seller includes dosing instructions with the order?

Stop and reconsider the supplier entirely. Research chemical suppliers cannot lawfully provide human dosing, administration, or protocol guidance, and one that does is signaling either inexperience or indifference toward the rules governing research-use-only material. That same indifference tends to surface in documentation and quality control. It is one of the clearest reasons to source somewhere else.

The blunt truth about the cheapest vial on the page

Here is the honest answer: the cheapest place to buy PT-141 is usually cheap for a reason you can measure, and the reason is almost always purification. Peptides can be sold crude, once-purified, or twice-purified, and every additional pass costs yield and money. A price far below everyone else means a skipped purification step, a fill to gross mass instead of net peptide mass, or no third-party analysis to pay for. None of those are scandals. They are choices that change your data, and you should know which one you bought.

If you want to check our work before ordering, the batch certificates are published by lot, and the PT-141 product page lists purity, fill, and handling details for the current batch. Researchers comparing compounds across a project can browse the full research catalog, read the PT-141 research overview and the PT-141 FAQ, or check where we ship before deciding where to buy PT-141 for a study.

The decision about where to buy PT-141 looks like a purchasing question and behaves like a methodology question. A vial with no traceable certificate introduces a variable you cannot control for and cannot report, which quietly converts every downstream result into an estimate. Analytical documentation is not administrative overhead. It is the part of the experiment that happens before the experiment, and researchers who treat it that way spend far less time wondering whether a strange result came from the biology or from the bottle.

References

Peer-reviewed sources on PT-141 (Bremelanotide) indexed in PubMed, listed for research context. Real Peptides supplies PT-141 (Bremelanotide) for laboratory research use only.

Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder. Journal of sex research, 2024. PMID 36809187. doi:10.1080/00224499.2023.2175192
An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. Expert opinion on pharmacotherapy, 2023. PMID 36242769. doi:10.1080/14656566.2022.2132144
Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurology international, 2022. PMID 35076581. doi:10.3390/neurolint14010006
The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. CNS spectrums, 2022. PMID 33455598. doi:10.1017/S109285292100002X
Safety Profile of Bremelanotide Across the Clinical Development Program. Journal of women's health (2002), 2022. PMID 35147466. doi:10.1089/jwh.2021.0191
Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. Journal of women's health (2002), 2022. PMID 35230162. doi:10.1089/jwh.2021.0225
Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women. Journal of sex research, 2021. PMID 33678061. doi:10.1080/00224499.2021.1885601
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent. Drug and therapeutics bulletin, 2021. PMID 34642243. doi:10.1136/dtb.2021.000020

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Check for a batch-specific certificate of analysis that shows both HPLC purity and mass spectrometry identity confirmation, and verify the lot number on that certificate matches the lot printed on the vial. Ask separately for net peptide content, since trifluoroacetic acid counterion and residual moisture make up part of the powder mass. A supplier that cannot produce lot-matched analytics has nothing to verify.

Research-grade PT-141 is sold for laboratory and research use only, and reputable suppliers require buyers to agree to research-use-only terms at checkout. The compound is not an approved drug product and is not sold for human or veterinary consumption. Anyone seeking bremelanotide for personal use needs a prescription for the approved product from a licensed prescriber, which is a completely separate channel from research supply.

Price differences usually reflect purification depth and fill practice rather than the sequence itself. Crude or single-pass peptide is substantially cheaper to produce than twice-purified material, and a vial filled to gross mass rather than net peptide mass looks identical on the label while containing less compound. Third-party analytical testing also carries real cost, which is why suppliers with no published certificates can quote lower.

Vyleesi is a finished, sterile, prescription drug product containing bremelanotide in a subcutaneous autoinjector, developed by Palatin Technologies and approved by the FDA in 2019 for hypoactive sexual desire disorder in premenopausal women. Research-grade PT-141 is lyophilized bremelanotide powder supplied for laboratory work, with no approved formulation, no prescribing information, and no clinical indication. They share an active sequence and nothing else.

PT-141 acts as a non-selective melanocortin receptor agonist with activity at MC1R, MC3R, and MC4R, and the research literature attributes its effects on sexual function to central MC4R signaling in the hypothalamus. Sildenafil is a PDE5 inhibitor that works peripherally, increasing cyclic GMP in vascular smooth muscle to promote blood flow. One pathway is central and neurological, the other is peripheral and vascular.

They are closely related but not identical. Bremelanotide is the deaminated metabolite of Melanotan II and retains melanocortin receptor agonist activity while showing substantially less effect on melanogenesis, which is the pigmentation pathway Melanotan II is known for. Both are alpha-MSH analogues, and both are supplied as research compounds rather than approved products.

Lyophilized peptide is typically held frozen for long-term storage and kept sealed and protected from light and moisture, while short ambient exposure during shipping is generally tolerated in dry form. Once a vial is reconstituted, the solution is far less stable and is stored refrigerated, light-protected, and used within a limited window. Storage conditions for a specific batch should follow the handling notes on that batch certificate.

The core risk is that nothing is verifiable after purchase. Marketplace and social listings rarely provide lot-matched certificates, which means purity, identity, and net peptide content are unknown, and accounts often change between orders so there is no recourse for a bad batch. For any work where concentration accuracy affects the result, an unverifiable vial invalidates the data before the experiment starts.

Net peptide content is the percentage of the vial mass that is actual peptide, as opposed to trifluoroacetic acid counterion left over from solid-phase synthesis and residual water retained after lyophilization. It is reported by amino acid analysis and is a different figure from HPLC purity. A vial can be 99% pure and still deliver less than its stated milligram weight in peptide, which is why both numbers belong on the same certificate.

Not on its own. Purity describes how much of the material is the target sequence relative to impurities, but it says nothing about whether the target sequence is actually bremelanotide, which is what mass spectrometry confirms, or how much peptide the vial contains by weight. A certificate showing purity alone, with no identity confirmation and no peptide content figure, is incomplete documentation.

Transit time varies by supplier and destination, and lyophilized powder in sealed vials is generally stable across several days at ambient temperature, which is why most research suppliers ship dry rather than frozen. Extended exposure to high heat is still a concern, so packages should be inspected and logged on arrival. If conditions look questionable, contact the supplier before opening the vial, since visual inspection cannot confirm sequence integrity.

At minimum, a lot-numbered vial, a batch-specific certificate of analysis with HPLC chromatogram and mass spectrometry data, clear research-use-only labeling, and stated handling and storage conditions. Suppliers that maintain a public certificate archive by lot make verification straightforward before you place an order rather than after. Absence of any of those items is a sourcing decision in itself.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA